CAPTRUST FINANCIAL ADVISORS
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1512024
RALEIGH, NC
Position in REGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$29,748,185
+$13,400,751 QoQ
Shares Held
38,502
+81.8% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 58.41514726507714.ToString("F0")%
Shared 0.ToString("F0")%
None 41.58485273492286.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CAPTRUST FINANCIAL ADVISORS holds $130,226,430 across 94 Biotechnology names. REGN ranks #1 (22.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
38,502 | $29,748,185 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
32,092 | $14,330,361 | |
| 3 | EXEL |
Exelixis, Inc.
|
312,296 | $13,394,375 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
121,088 | $7,825,917 | |
| 5 | CELC |
Celcuity Inc.
|
61,068 | $6,970,301 | |
| 6 | RPRX |
Royalty Pharma plc
|
143,760 | $6,896,167 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
29,900 | $5,969,535 | |
| 8 | INCY |
Incyte Corp
|
53,555 | $5,040,596 |
All Filings in REGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $29,748,185 | 38,502 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $16,347,434 | 21,179 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $8,106,246 | 14,417 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $5,629,575 | 10,723 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $9,061,878 | 14,288 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $7,063,464 | 9,916 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $9,597,821 | 9,130 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $9,284,799 | 8,834 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $8,565,198 | 8,899 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $11,017,269 | 12,544 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $10,254,904 | 12,461 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $8,675,651 | 12,074 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $10,190,351 | 12,402 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $9,143,442 | 12,673 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $7,900,650 | 11,469 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $6,293,761 | 10,647 | Shares | Sole | 2022-08-23 | |
| 2022-03-31 | $6,605,656 | 9,458 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $6,254,574 | 9,904 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,951,220 | 6,529 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $1,057,316 | 1,893 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $893,761 | 1,889 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $898,101 | 1,859 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,186,733 | 2,120 | Shares | Sole | 2020-11-17 | |
| 2020-06-30 | $1,052,721 | 1,688 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $730,481 | 1,496 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||